<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
  <meta name="description" content="https://www.rbio.online/
  Synthetic biotechnology techniques for insulin manufacturing to make diabetes cure more affordable and accessible. " />
  <meta name="author" content="" />
  <title>Insulin Manufacturing | RBIO | United States</title>
  <link rel="icon" type="image/x-icon" href="images\logo.png" />
  <!-- Font Awesome icons (free version)-->
  <script src="https://use.fontawesome.com/releases/v5.13.0/js/all.js" crossorigin="anonymous"></script>
  <!-- Google fonts-->
  <link href="https://fonts.googleapis.com/css2?family=Libre+Baskerville:wght@700&display=swap" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css2?family=Red+Rose&display=swap" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css2?family=Merriweather&display=swap" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css2?family=Marcellus&display=swap" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@500&family=Nanum+Gothic:wght@700&display=swap" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Montserrat:400,700" rel="stylesheet" type="text/css" />
  <link href="https://fonts.googleapis.com/css?family=Droid+Serif:400,700,400italic,700italic" rel="stylesheet" type="text/css" />
  <link href="https://fonts.googleapis.com/css?family=Roboto+Slab:400,100,300,700" rel="stylesheet" type="text/css" />
  <!-- Core theme CSS (includes Bootstrap)-->
  <link href="css/styles.css" rel="stylesheet" />
  <!-- Bootstrap -->
  <!-- CSS only -->
  <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.5.2/css/bootstrap.min.css" integrity="sha384-JcKb8q3iqJ61gNV9KGb8thSsNjpSL0n8PARn9HuZOnIxN0hoP+VmmDGMN5t9UJ0Z" crossorigin="anonymous">
</head>

<body id="page-top">
  <!-- Navigation-->
  <nav class="navbar navbar-expand-lg navbar-dark fixed-top  nav-black" id="mainNav">
    <div class="container-fluid ">
      <a class="navbar-brand js-scroll-trigger" href="index.html"><img class="brand-image" src="images\rbio vector fina.webp" alt="" /></a>

    </div>
  </nav>
  <!-- About 1 -->
  <header class="masthead2 ">
    <div class="container ">
      <div class="">
        <h2 class="section-heading ">About Us</h2>
        <div class=" paragraph-text">We are focused on addressing expensive treatment of diabetes and lack of insulin access globally</div>
      </div>
    </div>
  </header>

  <!-- About Us-->
  <section class="pb-5 tell-me-padding" id="tell-me-more">
    <div class="row row-cols-1 row-cols-md-2">
      <div class="col mb-4">
        <div class="card">
          <img src="images\dna-1903875_1280.jpg" class="card-img-top img-responsive img-fluid" alt="recombinant-dna">
          <div class="card-body">
            <p class="card-text">rBIO is a biotech company looking to bring pharmaceutical supply chains back to the USA by harnessing the power of recombinant DNA technologies. Single-celled organisms like yeast, bacteria, and algae represent the next manufacturing
              boom of biological products as the secrets of genetics continue to be unlocked. This coronavirus pandemic has highlighted gaps in the healthcare market and shown that America cannot rely on other countries to control the production of
              life-saving medication that its citizens rely on. Not only does rBIO have the potential to generate significant revenues from the sale of synthetic biological products, it is in national security interests to have these supply chains
              back on domestic soil. </p>
          </div>
        </div>
      </div>
      <div class="col mb-4">
        <div class="card">
          <img src="images\bacteria-3662695_1920.jpg" class="card-img-top img-responsive img-fluid" alt="ecoli">
          <div class="card-body">
            <p class="card-text">  To date, rBIO has secured lab space, purchased equipment, and designed 7 new strains of E. Coli bacteria to produce and express synthetic insulin, human growth hormone (HGH), erythropoietin (EPO), and follicle
                stimulating hormone (FSH). During lab testing of the protocols and procedures, yields will be determined and will be used as an important metric as the company grows into larger scale operations. Many other strains of synthetic
                bacteria could be designed to produce a host of other biological products, but insulin represents the best molecule to launch with due to the high prevalence and growth of type 2 diabetes here in the United States and worldwide.
            </p>
            <br>
          </div>
        </div>
      </div>
</div>
  </section>


</body>

<footer class="footer py-4">
  <div class="container">
    <div class="row align-items-center">
      <div class="col-lg-12">
        <a class="btn btn-primary btn-social mx-2" href="https://www.linkedin.com/company/rbio/about/"><i class="fab fa-linkedin-in"></i></a>
        <br><br>
      </div>
    </div>
  </div>
</footer>
